Skip to main content

Table 1 Characteristics of SSP participants inducted onto buprenorphine (N = 115)

From: Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs

 

n (%)

Age (in years)

 <30

17 (15%)

 30–39

35 (30%)

 40–49

32 (28%)

 ≥50

31 (27%)

Gender

 Cisgender male

83 (72%)

 Cisgender female

32 (28%)

Time to Induction

 Same Day as Referral

100 (87)

 One Day after Referral

7 (6)

 More than One Day after Referral

8 (7)

Payment method

 Medicaid/Medicare

106 (92%)

 Private

5 (4%)

 Self-pay

4 (4%)

Prescription refill

74 (64%)